Fundz

Rett Syndrome Research Trust Appoints Genevieve Laforet as Chief Medical Officer

PRIVATEApr 01, 2026

Position

Chief Medical Officer

Company

Rett Syndrome Research Trust

Genevieve Laforet
ConnecticutBiotechnologyHealth CareGeneticsNon Profit

Description

The Rett Syndrome Research Trust has announced the appointment of Genevieve Laforet, M.D., Ph.D., as its Chief Medical Officer. Dr. Laforet brings extensive experience in developing therapies for rare genetic neurological diseases.

Quick answer

Rett Syndrome Research Trust Appoints Genevieve Laforet as Chief Medical Officer (April 1, 2026). Rett Syndrome Research Trust is based in Connecticut, United States.

Who is the new Chief Medical Officer at Rett Syndrome Research Trust?
Rett Syndrome Research Trust named Genevieve Laforet Chief Medical Officer, announced April 1, 2026.
What did Rett Syndrome Research Trust announce on April 1, 2026?
The Rett Syndrome Research Trust has announced the appointment of Genevieve Laforet, M.D., Ph.D., as its Chief Medical Officer. Dr. Laforet brings extensive experience in developing therapies for rare genetic neurological diseases.
What does Rett Syndrome Research Trust do?
The Rett Syndrome Research Trust (RSRT) is an organization dedicated to curing Rett syndrome, a rare genetic neurodevelopmental disorder.
Where is Rett Syndrome Research Trust based?
Rett Syndrome Research Trust is based in Connecticut, United States.
Which similar companies made leadership changes around the same time?
The National Biosafety Authority (NBA) (April 3, 2026), UNC Health (April 6, 2026), RetinalGeniX Technologies (March 26, 2026) and Research!America (April 7, 2026) also announced leadership changes within 45 days of Rett Syndrome Research Trust.

Source: Fundz verified event record.

Other recent leadership changes in Genetics and Non Profit

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Rett Syndrome Research Trust, and when

A new leader at Rett Syndrome Research Trust brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Rett Syndrome Research Trust raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Rett Syndrome Research Trust, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Rett Syndrome Research Trust. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Rett Syndrome Research Trust

Location

Connecticut, United States

About

The Rett Syndrome Research Trust (RSRT) is an organization dedicated to curing Rett syndrome, a rare genetic neurodevelopmental disorder. RSRT focuses on advancing genetic medicine programs and conducting research aimed at developing therapies for Rett syndrome. The organization collaborates with various biopharma partners to push therapeutic programs from concept to clinical application.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Rett Syndrome Research Trust changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jana
Senior decision-maker at this company
••••••••@••••••••

See Jana's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Rett Syndrome Research Trust's next move

Learn about Strategic plan

Rett Syndrome Research Trust changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.